Category: Prescription Drugs
United States Prescription Drugs
-
Rx/Reimbursement Adult Incontinence in the US
... of continuous enrolment, which officially ended in March 2023, with some states winding down disenrollment until June 2024. According to the nonprofit organisation Kaiser Family Foundation (KFF), 23 million people have been disenrolle... Euromonitor International's ... Read More
-
The U.S. Weight Loss & Diet Control Market: Commercial (non-medical) Programs & Products
... hurt the most since 2022. Commercial weight loss firms lost $2 billion in sales to the GLP-1 drugs market. The business has gone virtual, and some competitors have added the GLP-1 drugs to their programs ... Read More
-
Pet Medications in the US, 9th Edition
... for dogs and cats reached $12.6 billion in 2024 and is projected to grow at a moderate pace through 2029. Growth is dependent upon a return to financial stability, a recovery in the dog population, ... Read More
-
U.S. Tardive Dyskinesia Treatment Market - 2024 - 2031
... Tardive dyskinesia (TD) is a neurological disease noted by involuntary, repetitive movements. The disease often results from long-term use of certain medications, particularly antipsychotics, prescribed for psychiatric conditions like schizophrenia and bipolar disorder. Symptoms include ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end ... Read More
-
U.S. E-Prescribing Market - Focused Insights 2025-2030
... announced that it is integrating e-prescribing and medication management solutions from health technology pioneer DrFirst into its CDS system. In January 2022, Oracle announced its acquisition of Cerner Corporation, a leading supplier of health information ... Read More
-
2025 United States Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-High Tech Outlook Report
... is within the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. ... Read More
-
Pharmaceuticals: United States
... of: compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, nutritional, respiratory, dermatological, and digestive and genito-urinary. To illustrate historical trends, total ... Read More
-
Ophthalmic Drugs Market Report 2025-2035
... underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The global ophthalmic drugs market is experiencing robust growth, ... Read More
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... market was valued at $2551.32 million in 2023 and is expected to reach a revenue of $4237.32 million by 2032. MARKET INSIGHTS The United States Alzheimer’s disease therapeutics & diagnostics industry is growing rapidly, escalated ... Read More
-
2024 United States Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United States Pharma E-Commerce Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024-2029 Global Drugs of Abuse Testing Market for 12 Assays - US, Europe, Japan - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This new report from LeadingMarketResearch.com provides analysis of the global drug of abuse testing market, including emerging tests, ... Read More
-
Pharmaceuticals in the US: ISIC 2423
... ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of ... Read More
-
Healthcare Consultants in the US - Industry Market Research Report
... manage risk. Over the five years to 2023, demand for healthcare consultants has increased because of technological advances in healthcare-related industries and the changing regulatory environment. Moreover, the 2010 Patient Protection and Affordable Care Act ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in the US
... normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most paediatric and adult cough and cold categories are expected to see slight negative growth in 2024, overall decline is mainly ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
Pharmacy Market in Us 2024-2028
... market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
Research Assistance
